256 related articles for article (PubMed ID: 2848225)
1. 99mTc-aminohexylidendiphosphonate and 99mTc-pyrophosphate in the scintigraphic diagnosis of experimental myocardial infarction in dogs.
Duska F; Hadas L; Vizda J; Kafka P; Urbanová E; Palicka V; Mazurová Y; Kuba M; Grossman V
Nuklearmedizin; 1988 Oct; 27(5):226-7. PubMed ID: 2848225
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-aminohexylidendiphosphonate and 99mTc-pyrophosphate in the scintigraphic diagnosis of experimental cardiomyopathy in dogs.
Duska F; Hadas L; Vizda J; Kafka P; Mazurová Y; Palicka V; Grossman V
Nuklearmedizin; 1987 Oct; 26(5):220-3. PubMed ID: 2829138
[TBL] [Abstract][Full Text] [Related]
3. Radiopharmaceuticals for myocardial infarct imaging: a clinical comparison of 99Tcm-pyrophosphate and 99Tcm-dimethylaminomethylene diphosphonate.
Bell D; Millar AM; Grayshan R; Muir AL
Br J Radiol; 1988 Jul; 61(727):646-8. PubMed ID: 2841991
[No Abstract] [Full Text] [Related]
4. Evaluation of [99mTc]N-phosphorylaminoethyl-phosphate [( 99mTc]PAEP) as imaging agent in acute myocardial infarction.
Chiotellis E; Varvarigou A; Smirniotis B; Papadimitriou J
Int J Nucl Med Biol; 1984; 11(3-4):280-2. PubMed ID: 6099342
[No Abstract] [Full Text] [Related]
5. Time course of 99mTc-pyrophosphate and 99mTc-gluconate uptake in experimental ischaemic myocardial necrosis.
Kasalický J; Riedel A; Konopková M
Radiobiol Radiother (Berl); 1985; 26(5):641-50. PubMed ID: 3003790
[No Abstract] [Full Text] [Related]
6. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
8. Detection of acute myocardial infarcts by infarct-avid imaging.
Willerson JT
J Nucl Med; 1991 Feb; 32(2):269-71. PubMed ID: 1846912
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of positive myocardial imaging.
Hale TI; Jucker A
Eur J Nucl Med; 1984; 9(11):525-6. PubMed ID: 6097450
[No Abstract] [Full Text] [Related]
10. [The pathophysiologic basis for the incorporation of 99mTc-pyrophosphate into myocardial infarct].
Duska F; Hadas L; Volenec K; Palicka V; Mazurová Y; Vizd'a J; Kafka P; Urbanová E; Kuba M; Veverková O
Cesk Radiol; 1989 Aug; 43(4):241-9. PubMed ID: 2551518
[TBL] [Abstract][Full Text] [Related]
11. [Characteristics of 99m Tc-pyrophosphate images in the myocardium of aged patients].
Samoĭlenko LE; Malov AG
Med Radiol (Mosk); 1991; 36(4):16-8. PubMed ID: 1851923
[TBL] [Abstract][Full Text] [Related]
12. Comparison of indium-111 antimyosin antibody and technetium-99m pyrophosphate localization in reperfused and nonreperfused myocardial infarction.
Takeda K; LaFrance ND; Weisman HF; Wagner HN; Becker LC
J Am Coll Cardiol; 1991 Feb; 17(2):519-26. PubMed ID: 1846888
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of the gluconate and pyrophosphate heart scan in the diagnosis of acute transmural myocardial infarctions].
Duska F; Kubícek J; Novák J; Vizdá J; Kafka P; Bastecký J
Cesk Radiol; 1982 Nov; 36(6):402-9. PubMed ID: 6297812
[No Abstract] [Full Text] [Related]
14. Technetium-99m pyrophosphate and indium-111 antimyosin antibody scintigraphy appear to be comparable methods for infarct detection.
Willerson JT; Buja LM
J Am Coll Cardiol; 1991 Feb; 17(2):527-9. PubMed ID: 1846889
[No Abstract] [Full Text] [Related]
15. Scintigraphic myocardial imaging with 99mTC-labelled pyrophosphate of experimentally produced cardiomyopathy in dogs.
Duska F; Novák J; Vizda J; Kubícek J; Kafka P; Mazurova Y; Bradna P
Nuklearmedizin; 1981 Dec; 20(6):265-7. PubMed ID: 6276862
[TBL] [Abstract][Full Text] [Related]
16. 99mTc-labelled pyrophosphate myocardial scanning in experiment and in clinical practice.
Vizda J; Duska F; Kubícek J; Kafka P; Novák J; Mazurová Y
Cor Vasa; 1981; 23(6):457-66. PubMed ID: 6277567
[TBL] [Abstract][Full Text] [Related]
17. Myocardial distribution of indium-111-antimyosin Fab in acute inferior and right ventricular infarction: comparison with technetium-99m-pyrophosphate imaging and histologic examination.
Nakata T; Sakakibara T; Noto T; Shoji T; Tsuda T; Kubota M; Hattori A; Iimura O
J Nucl Med; 1991 May; 32(5):865-7. PubMed ID: 1850785
[TBL] [Abstract][Full Text] [Related]
18. [99mTc-pyrophosphate scintigraphic indices at different times in acute myocardial infarct].
Vinogradov AV; Sycheva IM; Rylova AK; Gel'fand IN; Demidov AS
Kardiologiia; 1981 Aug; 21(8):44-7. PubMed ID: 6270443
[TBL] [Abstract][Full Text] [Related]
19. Use of pyrophosphate labelled with 99mTc in the scintigraphic diagnosis of myocardial infarction.
Kubicek J; Vizda J; Duska F
Nuklearmedizin; 1977 Aug; 16(4):147-50. PubMed ID: 198751
[No Abstract] [Full Text] [Related]
20. Myocardial infarct imaging: superiority of inorganic agents over organic diphosphonates.
Logic JR; Meyer-Pavel CM; Blackman J
J Nucl Med; 1981 Jul; 22(7):659-70. PubMed ID: 6265610
[No Abstract] [Full Text] [Related]
[Next] [New Search]
